ATE241640T1 - Fusidinsäure-derivate - Google Patents

Fusidinsäure-derivate

Info

Publication number
ATE241640T1
ATE241640T1 AT00967616T AT00967616T ATE241640T1 AT E241640 T1 ATE241640 T1 AT E241640T1 AT 00967616 T AT00967616 T AT 00967616T AT 00967616 T AT00967616 T AT 00967616T AT E241640 T1 ATE241640 T1 AT E241640T1
Authority
AT
Austria
Prior art keywords
acid derivatives
fusidic acid
treatment
infections
skin
Prior art date
Application number
AT00967616T
Other languages
English (en)
Inventor
Tore Duvold
Daehne Welf Von
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of ATE241640T1 publication Critical patent/ATE241640T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00967616T 1999-10-15 2000-10-12 Fusidinsäure-derivate ATE241640T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15955799P 1999-10-15 1999-10-15
PCT/DK2000/000578 WO2001029061A1 (en) 1999-10-15 2000-10-12 Novel fusidic acid derivatives

Publications (1)

Publication Number Publication Date
ATE241640T1 true ATE241640T1 (de) 2003-06-15

Family

ID=22573055

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00967616T ATE241640T1 (de) 1999-10-15 2000-10-12 Fusidinsäure-derivate

Country Status (20)

Country Link
US (1) US6593319B1 (de)
EP (1) EP1232173B1 (de)
JP (1) JP2003512386A (de)
KR (1) KR100795321B1 (de)
CN (1) CN1157404C (de)
AT (1) ATE241640T1 (de)
AU (1) AU777352B2 (de)
BR (1) BR0014751A (de)
CA (1) CA2387600C (de)
CZ (1) CZ20021265A3 (de)
DE (1) DE60003074T2 (de)
DK (1) DK1232173T3 (de)
ES (1) ES2199867T3 (de)
HU (1) HUP0203454A3 (de)
MX (1) MXPA02003731A (de)
NZ (1) NZ518034A (de)
PL (1) PL203312B1 (de)
PT (1) PT1232173E (de)
RU (1) RU2257391C2 (de)
WO (1) WO2001029061A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140194A (en) * 2003-07-16 2009-11-30 Leo Pharma As Novel fusidic acid derivatives
US20060230643A1 (en) * 2005-03-23 2006-10-19 Michael Affleck Footwear with additional comfort
WO2007051468A2 (en) * 2005-10-31 2007-05-10 Leo Pharma A/S Preparation of an antibiotic crystalline fusidic acid
WO2007066339A1 (en) 2005-12-07 2007-06-14 Ramot At Tel Aviv University Ltd. Drug-delivering composite structures
UA116622C2 (uk) * 2011-11-11 2018-04-25 Аллерган, Інк. Похідні 4-прегенен-11ss-17-21-тріол-3,20-діону для лікування хвороб очей

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135267A (de) 1971-02-25
US4162259A (en) 1975-12-03 1979-07-24 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske fabrik Produktionsaktienselskab) Fusidic acid derivatives
US4259333A (en) 1977-10-28 1981-03-31 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Cephalosporines
GB2013084B (en) 1978-01-25 1982-07-28 Alcon Lab Inc Ophthalmic drug dosage
DE2964471D1 (en) 1979-06-08 1983-02-17 Toko Yakuhin Kogyo Kk Creamy preparation containing steroid and process for the preparation thereof
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US4959358A (en) * 1983-06-06 1990-09-25 Beth Israel Hospital Assn. Drug administration
GB8500310D0 (en) 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
RU1499922C (ru) * 1987-12-25 1995-08-09 Государственный научный центр по антибиотикам Способ получения фузидиевой кислоты и ее натриевой соли
IE892257A1 (en) * 1989-07-13 1991-02-13 Elan Corp Anti-infective agent, process for its preparation and its¹use in therapy
US6103884A (en) 1996-03-27 2000-08-15 The University Of Michigan Glycosylated analogs of fusidic acid
AU2002235729A1 (en) * 2001-03-08 2002-09-19 Leo Pharma A/S Fusidic acid derivatives

Also Published As

Publication number Publication date
DE60003074T2 (de) 2004-03-18
RU2257391C2 (ru) 2005-07-27
HK1050203A1 (en) 2003-06-13
BR0014751A (pt) 2002-07-02
AU777352B2 (en) 2004-10-14
PL203312B1 (pl) 2009-09-30
CZ20021265A3 (cs) 2003-02-12
ES2199867T3 (es) 2004-03-01
KR20030022760A (ko) 2003-03-17
JP2003512386A (ja) 2003-04-02
EP1232173A1 (de) 2002-08-21
CA2387600A1 (en) 2001-04-26
US6593319B1 (en) 2003-07-15
EP1232173B1 (de) 2003-05-28
NZ518034A (en) 2003-10-31
DK1232173T3 (da) 2003-09-29
CN1157404C (zh) 2004-07-14
DE60003074D1 (de) 2003-07-03
KR100795321B1 (ko) 2008-01-21
HUP0203454A2 (hu) 2003-02-28
PL355113A1 (en) 2004-04-05
AU7772800A (en) 2001-04-30
WO2001029061A1 (en) 2001-04-26
HUP0203454A3 (en) 2004-07-28
CN1378554A (zh) 2002-11-06
CA2387600C (en) 2007-08-21
MXPA02003731A (es) 2003-12-11
PT1232173E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
BR0014078A (pt) Inibidores de fator xa
BR9801652A (pt) Resorcinil-triazinas
TR200200068T2 (tr) Nematisital triflüorobütenler
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
PL361341A1 (pl) Nowa kompozycja farmaceutyczna
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
EP1319402A4 (de) IgE-ENTSTEHUNGSHEMMSTOFFE
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
SE9802208D0 (sv) Novel compounds
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
NO20010940L (no) TAN-1057 derivater
SE9802209D0 (sv) Novel compounds
DE60003074D1 (de) Fusidinsäure-derivate
SE0001916D0 (sv) Novel formulation
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1232173

Country of ref document: EP

REN Ceased due to non-payment of the annual fee